Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
D000547:Amantadine / Q000494:pharmacology; D000701:Analgesics, Opioid; D000818:Animals; D000978:Antiparkinson Agents; D001058:Apomorphine / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001545:Benserazide / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D002389:Catatonia / Q000139:chemically induced*; D003913:Dextroamphetamine / Q000494:pharmacology; D003916:Dextromoramide / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004149:Dioxoles / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D009020:Morphine / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014282:Trihexyphenidyl / Q000494:pharmacology
D000701:Analgesics, Opioid; D000978:Antiparkinson Agents; D001593:Benzyl Compounds; D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D001545:Benserazide; D009020:Morphine; D001285:Atropine; D003916:Dextromoramide; D000547:Amantadine; D001058:Apomorphine; D003913:Dextroamphetamine